StreetInsider.com News Articles

Adia Med Finds Another Unicorn

Tue, 30 Jun 2026 12:49:00 -0400

CEO Larry Powalisz Spotlights Dr. Lyday, a Leading Stem Cell Champion, in New Podcast.

Winter Park, Florida--(Newsfile Corp. - June 30, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine and stem cell therapies company, today announced that CEO Larry Powalisz recently sat down for a podcast interview with Dr. Lyday, a physician recognized as a champion for stem cell-based treatments.

Dr. Lyday and CEO Larry Powalisz Podcast

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/303481_adia.jpg

During the conversation, Powalisz affectionately referred

Adia Med Finds Another Unicorn

Tue, 30 Jun 2026 12:49:00 -0400

CEO Larry Powalisz Spotlights Dr. Lyday, a Leading Stem Cell Champion, in New Podcast.

Dr. Lyday and CEO Larry Powalisz Podcast

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/303481_adia.jpg

During the conversation, Powalisz affectionately referred

Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training

Tue, 16 Jun 2026 10:55:00 -0400

Dr. Brian Browning to train APRNs and RNs on Butterfly portable ultrasound for more precise, comfortable, and reliable IV therapies

Winter Park, Florida--(Newsfile Corp. - June 16, 2026) - Adia Med, the regenerative medicine and advanced IV therapy division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a major step forward in patient care quality. Renowned physician Dr. Brian Browning, DO, Lead Physician at Adia Med, will personally train the company's Advanced Practice Registered Nurses (APRNs) and Registered Nurses (RNs) in ultrasound-guided intravenous (IV) insertions and administrations using the innovative Butterfly portable ultrasound device.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/300817_screenshot_adia_med_inc_official_on_nevada.jpg

The move is more than cosmetic — it's a clear signal of where Adia is headed. Shifting from "Nutrition" to "Med" puts the spotlight on the company's growing emphasis on advanced medical and wellness solutions. The new name captures Adia's drive

Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada

Wed, 10 Jun 2026 09:15:00 -0400

Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the State of Nevada has officially approved the company's name change to Adia Med Inc.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/300817_screenshot_adia_med_inc_official_on_nevada.jpg

Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions

Mon, 08 Jun 2026 12:51:00 -0400

Winter Park, Florida--(Newsfile Corp. - June 8, 2026) - Adia Nutrition (OTCQB: ADIA), a leader in advanced nutrition and regenerative health products, today announced the official launch of its new wholly-owned subsidiary, ADIA Life LLC, headquartered in the state of Florida.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/300531_screenshot_adia_life_llc_registration.jpg

ADIA Life LLC was strategically created to serve as the central hub for managing distribution of Adia Labs' cutting-edge products while also overseeing a growing network of authorized distributors nationwide. But that's just the

Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions

Mon, 08 Jun 2026 12:51:00 -0400

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/300531_screenshot_adia_life_llc_registration.jpg

Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)

Tue, 02 Jun 2026 09:30:00 -0400

Winter Park, Florida--(Newsfile Corp. - June 2, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) is thrilled to announce that the powerful new documentary showcasing TNA Wrestling star and former WWE superstar Jeff Sciullo, known to fans worldwide as Elias (or Elijah), is in final editing and racing toward release!

Wrestler's Tricep Tears Off Bone During Match! #shorts

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/299721_adia.jpg

The film captures Sciullo's jaw-dropping comeback from a devastating tricep tendon tear - completely ripped off

Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)

Tue, 02 Jun 2026 09:30:00 -0400

Wrestler's Tricep Tears Off Bone During Match! #shorts

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/299721_adia.jpg

The film captures Sciullo's jaw-dropping comeback from a devastating tricep tendon tear - completely ripped off

Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry

Tue, 26 May 2026 08:00:00 -0400

Winter Park, Florida--(Newsfile Corp. - May 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine and innovative healthcare solutions, today announced that an independent monthly-membership health care sharing ministry — where members pay monthly dues as an alternative to traditional health insurance — now accepts up to three stem cell treatments per client.

This expanded coverage provides eligible members with greater access to advanced stem cell therapies for regenerative applications. A family of three is currently undergoing treatment with AdiaVita at one of the company's affiliate clinics, demonstrating the real-world impact of this new benefit.

The health care

Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry

Tue, 26 May 2026 08:00:00 -0400

The health care

Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov

Wed, 20 May 2026 11:58:00 -0400

Winter Park, Florida--(Newsfile Corp. - May 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine, today announced that its subsidiary Adia Med of Winter Park LLC is now actively recruiting participants for two key clinical studies officially listed as "Recruiting" on ClinicalTrials.gov.

https://clinicaltrials.gov/study/NCT07572890#study-overview

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/298208_kidneystudy.jpg

Each study is enrolling up to 100 participants. The Kidney Health Study (NCT07572890 - Adia Med of Winter Park LLC Chronic Kidney Disease

Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov

Wed, 20 May 2026 11:58:00 -0400

https://clinicaltrials.gov/study/NCT07572890#study-overview

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/298208_kidneystudy.jpg

Each study is enrolling up to 100 participants. The Kidney Health Study (NCT07572890 - Adia Med of Winter Park LLC Chronic Kidney Disease

ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026

Fri, 15 May 2026 07:59:00 -0400

Winter Park, Florida--(Newsfile Corp. - May 15, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced nutrition and regenerative health solutions, today announced its 3^rd party reviewed financial results for the first quarter ended March 31, 2026, highlighting significant year-over-year revenue growth and continued expansion of its biologics and medical procedures segments.

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001160420/000168316826003957/adia_i10q-033126.htm

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/297620_adia_image1.jpg

Key Highlights for Q1 2026 (compared to Q1 2025):

Total Revenue increased 146% to $176,275 from

ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026

Fri, 15 May 2026 07:59:00 -0400

Key Highlights for Q1 2026 (compared to Q1 2025):

Total Revenue increased 146% to $176,275 from

Form 10-Q Adia Nutrition, Inc. For: Mar 31

Fri, 15 May 2026 06:13:00 -0400

si-local-file:///var/storage/secattach/20260515/26498531.html

Form 10-Q Adia Nutrition, Inc. For: Mar 31

Fri, 15 May 2026 06:13:00 -0400

si-local-file:///var/storage/secattach/20260515/26498531.html

ADIA Nutrition receives IRB approval for four clinical studies

Mon, 11 May 2026 10:12:55 -0400

ADIA Nutrition Inc. (OTCQB: ADIA) announced that all four of its planned clinical studies have received Institutional Review Board approval. The company's subsidiary Adia Med of Winter Park, LLC is conducting trials evaluating AdiaVita stem cell and exosome therapies.

The kidney health study, which evaluates AdiaVita combined with glutathione in adults with Stage 2-4 Chronic Kidney Disease, has been registered on ClinicalTrials.gov under identifier NCT07572890. Recruitment for this study is scheduled to begin this week.

The Winter Park Autism Spectrum Disorder Research Study (NCT07304440) has completed recruitment and is treating enrolled patients. This 24-month study evaluates AdiaVita combined with glutathione therapy in

ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov

Mon, 11 May 2026 10:04:00 -0400

Winter Park Autism Study Now Treating Patients; Kidney Study Recruitment to Begin This Week

Winter Park, Florida--(Newsfile Corp. - May 11, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine through its subsidiary Adia Med of Winter Park, LLC, today announced that all four of its planned clinical studies have received Institutional Review Board (IRB) approval. This milestone enables the continued execution and launch of human trials evaluating the safety and potential efficacy of the Company's proprietary AdiaVita™ stem cell and exosome therapies.

ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov

Mon, 11 May 2026 10:04:00 -0400

Winter Park Autism Study Now Treating Patients; Kidney Study Recruitment to Begin This Week

Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)

Tue, 05 May 2026 10:08:00 -0400

Winter Park, Florida--(Newsfile Corp. - May 5, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company based in Winter Park, Florida, dedicated to advancing regenerative therapies for chronic diseases, today announced that its pivotal clinical study on kidney disease has received Institutional Review Board (IRB) approval and has been successfully submitted to ClinicalTrials.gov.

Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/295970_ckdstudy.jpg

This

Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)

Tue, 05 May 2026 10:08:00 -0400

Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/295970_ckdstudy.jpg

This

Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight

Tue, 28 Apr 2026 08:30:00 -0400

Winter Park, Florida--(Newsfile Corp. - April 28, 2026) - Adia Nutrition, (OTCQB: ADIA) a leader in advanced regenerative health solutions, today announced a major milestone in its clinical research pipeline.

Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/294388_adiaimage.jpg

The company has successfully received the second round of comments back from the Institutional Review Board (IRB) for its Lower Back Pain Study. This randomized, placebo-controlled